FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Related Tags >> obesity   lorcaserin   Phase III   FDA
Syndicate content

Arena Pharmaceuticals News

Most Popular Arena Pharmaceuticals Story

Arena gets 10/22 PDUFA date for lorcaserin

Arena Pharmaceuticals should know by October 22 if its closely-watched obesity drug--lorcaserin--will win approval by the FDA. The drug is widely viewed as a likely blockbuster if it breaks into the... Read more...

Latest Headlines